Truist maintained its Buy rating on Mid-America Apartment Communities (MAA) but trimmed its price target to $142 from $146 due to softening Sun Belt job growth. RBC Capital also raised its price target on Design Therapeutics (DSGN) to $14 from $13 ahead of key pipeline data expected in the second half of 2026.